Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 61

Sort by

Sort Order Select

Journal Articles

Tumor Associated Antigen Specific T Cells Given in Combination with Nivolumab for the Treatment of Hodgkin Lymphoma

Hema Dave, MDMPH, Mimi Mai, Madeline Terpilowski, BS, Keri Toner, MD, Maja Stanojevic, MD, Morgan Galligan, BS, Abeer Shibli, BS, Melanie Grant, PhD, Christopher Lazarski, PhD, Philip Y Maglo, BS, MPH, Nan Zhang, PhD, Jay Tanna, MS, Richard F. Ambinder, MD, Martha Glenn, MD, Patrick Hanley, PhD, Catherine M. Bollard, MD MBChB

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-142422

Published: 2020

Journal Articles

Cranial Radiation Can be Eliminated in Most Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Bortezomib Potentially Improves Survival in Children with T-Cell Lymphoblastic Lymphoma (T-LL): Results of Children's Oncology Group (COG) Trial AALL1231

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-134730

Published: 2020

Journal Articles

Increased Tumor Specific Cytotoxic T Cell Responses and Reversion to a Favorable Cytokine Profile after Treatment in Patients with Newly Diagnosed High Risk Hodgkin Lymphoma Treated on Children's Oncology Group Trial-AHOD1331

Hema Dave, Mimi Mai, Anushree Datar, Gaye Jenkins, BS, Qinglin Pei, PhD, Yue Wu, MS, Frank G. Keller, MD, Sharon M. Castellino, MD MSc, Terzah M Horton, MD PhD, Catherine M. Bollard, MD MBChB

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-136376

Published: 2020

Journal Articles

Blocking MAPK Activation and Immune Checkpoints Reverse Immune Dysfunction and Reduce Disease in a Mouse Model of LCH

Amel Sengal, BS, Meryl Hahne, Jessica Velasquez, Harshal Abhyankar, MS, Thomas Burke, BS, Walter Olea, Robert Reyes, Brooks Scull, MS, Camille Bigenwald, Catherine M. Bollard, MD, Wendong Yu, Miriam Merad, MD, Kenneth L. McClain, MD PhD, Carl E. Allen, MD PhD, Rikhia Chakraborty, PhD

Blood (2019) 134 (Supplement_1): 3602.

https://doi.org/10.1182/blood-2019-128253

Published: 2019

Journal Articles

Identifying Novel Immunodominant Epitopes within Human Parainfluenza Virus-3 Matrix Protein

Katherine Marie Harris, MD, Michael Keller, MD, Catherine M. Bollard, MD, Sarah Horn, BA, Christopher Lazarski, PhD, Gelina Sani, MS

Blood (2019) 134 (Supplement_1): 3251.

https://doi.org/10.1182/blood-2019-131898

Published: 2019

Journal Articles

Toxicity Profile of Brentuximab Vedotin in Combination with Chemotherapy for Newly Diagnosed Patients with ALK+ ALCL: A Children's Oncology Group Study ANHL12P1

Eric J Lowe, MD, Anne Reilly, MD, Catherine M. Bollard, MD, Donald A Barkauskas, Allen B Buxton, David Hall, Lauren Saguilig, John T. Sandlund, MD

Blood (2018) 132 (Supplement 1): 1625.

https://doi.org/10.1182/blood-2018-99-118450

Published: 2018

Journal Articles

Children's Oncology Group (COG) AALL0434: Successful Disease Control without Cranial Radiation in Newly Diagnosed T Lymphoblastic Lymphoma (T-LL)

Robert James Hayashi, Stuart S. Winter, MD, Kimberly P. Dunsmore, MD, Meenakshi Devidas, PhD, Brent Wood, MD PhD, Michelle L. Hermiston, MD PhD, David T Teachey, MD, Sherrie L. Perkins, MD PhD, Rodney R. Miles, MD PhD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Naomi Winick, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Megan S. Lim, MD,PhD, Catherine M. Bollard, MD, Thomas G. Gross, MD PhD

Blood (2018) 132 (Supplement 1): 1000.

https://doi.org/10.1182/blood-2018-99-113481

Published: 2018

Journal Articles

Hiv Specific T Cells Generated from HIV Naive Adult and Cord Blood Donors Target a Range of Novel Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT and CBT

Shabnum Patel, PhD, Shuroug Albihani, Elizabeth Williams, Julia Sung, Conrad Russell Young Cruz, MD PhD, R. Brad Jones, PhD, Elizabeth J Shpall, MD, David Margolis, Richard F Ambinder, MD, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 1010.

https://doi.org/10.1182/blood.V130.Suppl_1.1010.1010

Published: 2017

Journal Articles

Human Papillomavirus (HPV)--Specific T-Cells Can be Generated from Unimmunized Donors for Third Party Cell Therapy of HPV-Associated Neoplasms

Conrad Russell Young Cruz, MD PhD, Sarah McCormack, BA, Kaylor Elizabeth Wright, BS, Allison B Powell, BS, Haili Lang, MS, Cecilia Barese, MDPhD, Connie Trimble, MD, Michael Keller, MD, Ephraim J. Fuchs, MD MBA, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 1923.

https://doi.org/10.1182/blood.V130.Suppl_1.1923.1923

Published: 2017

Journal Articles

Clinical Use of CMV-Specific T Cells Derived from CMV-Naïve Donors

Patrick Hanley, PhD, Michael Keller, MD, Lauren Roesch, Devin Saunders, Haili Lang, Blachy Davila, MD, Ulrich A. Duffner, MD, Divyesh Kukadiya, Fahmida Hoq, MD, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 4470.

https://doi.org/10.1182/blood.V130.Suppl_1.4470.4470

Published: 2017

Journal Articles

Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients after HCT

Blood (2017) 130 (Supplement 1): 4516.

https://doi.org/10.1182/blood.V130.Suppl_1.4516.4516

Published: 2017

Journal Articles

Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 4073.

https://doi.org/10.1182/blood.V130.Suppl_1.4073.4073

Published: 2017

Journal Articles

Results of Inter-B-NHL Ritux 2010 - Phase II Study of DA-EPOCH-R for Children and Adolescents with Primary Mediastinal Large B-Cell Lymphoma (PMLBL) on Behalf of European Intergroup for Childhood Non Hodgkin's Lymphoma (EICNHL) and Children's Oncology Group (COG)

G A Amos Burke, Thomas G. Gross, MD PhD, Marta Pillon, Veronique Minard-colin, Raphael F Delgado, József Zsíros, Anne Uyttebroeck, Jean Michon, Catherine M. Bollard, MD FRACP, FRCPA, Monika Csoka, Donald A Barkauskas, Keith Wheatley, DPhil, Anne Aupérin, Catherine Patte

Blood (2017) 130 (Supplement 1): 4124.

https://doi.org/10.1182/blood.V130.Suppl_1.4124.4124

Published: 2017

Journal Articles

Rapidly-Generated EBV-Specific T Cells (EBVST-cells) to Treat Type 2 Latency Lymphoma

Rayne H. Rouce, MD, Birju Mehta, Sandhya Sharma, Serena Kimi Perna, MD, Benjamin Shin, Vicky Torrano, Fnu Spoorthi, Natalia Lapteva, PhD, Catherine M. Bollard, MD, Adrian P. Gee, PhD, Carlos A. Ramos, MD, Shannon Inman, Karen L. Hodgkin, Kurt C. Gunter, MD, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MD, Cliona M. Rooney, PhD

Blood (2016) 128 (22): 2990.

https://doi.org/10.1182/blood.V128.22.2990.2990

Published: 2016

Journal Articles

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Ifigeneia Tzannou, MD, Bilal Omer, MD, Anastasia Papadopoulou, PhD, Ulrike Gerdemann, MD, Colton Smith, PhD, Adrian P. Gee, PhD, Bambi J Grilley, Malcolm K. Brenner, MB, PhD FRCP, FRCPath, Catherine M. Bollard, MD, Ann M. Leen, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD

Blood (2015) 126 (23): 1926.

https://doi.org/10.1182/blood.V126.23.1926.1926

Published: 2015

Journal Articles

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Ann Leen, PhD, Ifigeneia Tzannou, MD, Munu Bilgi, Hao Liu, PhD, Juan F Vera, MD, Ulrike Gerdemann, MD, Rammurti T Kamble, MD, Carlos A. Ramos, MD, Bambi Grilley, RPh, Adrian P. Gee, PhD, Catherine M. Bollard, MD, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, George Carrum, MD

Blood (2015) 126 (23): 186.

https://doi.org/10.1182/blood.V126.23.186.186

Published: 2015

Journal Articles

Infusion of Ex Vivo Expanded Allogeneic Cord Blood-Derived Natural Killer Cells in Combination with Autologous Stem Cell Transplantation for Multiple Myeloma: Results of a Phase I Study

Blood (2015) 126 (23): 929.

https://doi.org/10.1182/blood.V126.23.929.929

Published: 2015

Journal Articles

Chimeric T Cells for Therapy of CD30+ Hodgkin and Non-Hodgkin Lymphomas

Carlos A. Ramos, MD, Brandon Ballard, BS, Enli Liu, MD MS, Olga Dakhova, PhD, Zhuyong Mei, MD, Hao Liu, PhD, Bambi Grilley, RPh, Cliona M. Rooney, PhD, Adrian P. Gee, PhD, Bill H. Chang, MD PhD, Catherine M. Bollard, MD, Malcolm K. Brenner, MD PhD, Gianpietro Dotti, MD, Helen E. Heslop, MD, Barbara Savoldo, MD PhD

Blood (2015) 126 (23): 185.

https://doi.org/10.1182/blood.V126.23.185.185

Published: 2015

Journal Articles

Graft Versus Leukemia Response without Graft Versus Host Disease Elicited By Adoptively Transferred Multivirus-Specific T-Cells

Paul A. Castillo, MD, Jan J Melenhorst, PhD, Patrick J Hanley, PhD, Michael Keller, MD, Robert A. Krance, MD, Judith Margolin, MD, Ann Leen, PhD, Helen E. Heslop, MD, John Barrett, MD, Cliona M Rooney, PhD, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2014) 124 (21): 2439.

https://doi.org/10.1182/blood.V124.21.2439.2439

Published: 2014

Journal Articles

Natural Killer Cells In Pediatric Acute Lymphoblastic Leukemia Patients At Diagnosis Demonstrate An Inhibitory Phenotype and Reduced Cytolytic Capacity

Rayne H. Rouce, MD, Takuya Sekine, Gerrit Weber, MD, Claude Chew, Katayoun Rezvani, M.D., PhD, Catherine M. Bollard, MD, FRACP, FRCPA, Karen R Rabin, MD, PhD

Blood (2013) 122 (21): 1397.

https://doi.org/10.1182/blood.V122.21.1397.1397

Published: 2013

NARROW

Tumor Associated Antigen Specific T Cells Given in Combination with Nivolumab for the Treatment of Hodgkin Lymphoma

Cranial Radiation Can be Eliminated in Most Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Bortezomib Potentially Improves Survival in Children with T-Cell Lymphoblastic Lymphoma (T-LL): Results of Children's Oncology Group (COG) Trial AALL1231

Increased Tumor Specific Cytotoxic T Cell Responses and Reversion to a Favorable Cytokine Profile after Treatment in Patients with Newly Diagnosed High Risk Hodgkin Lymphoma Treated on Children's Oncology Group Trial-AHOD1331

Blocking MAPK Activation and Immune Checkpoints Reverse Immune Dysfunction and Reduce Disease in a Mouse Model of LCH

Identifying Novel Immunodominant Epitopes within Human Parainfluenza Virus-3 Matrix Protein

Toxicity Profile of Brentuximab Vedotin in Combination with Chemotherapy for Newly Diagnosed Patients with ALK+ ALCL: A Children's Oncology Group Study ANHL12P1

Children's Oncology Group (COG) AALL0434: Successful Disease Control without Cranial Radiation in Newly Diagnosed T Lymphoblastic Lymphoma (T-LL)

Hiv Specific T Cells Generated from HIV Naive Adult and Cord Blood Donors Target a Range of Novel Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT and CBT

Human Papillomavirus (HPV)--Specific T-Cells Can be Generated from Unimmunized Donors for Third Party Cell Therapy of HPV-Associated Neoplasms

Clinical Use of CMV-Specific T Cells Derived from CMV-Naïve Donors

Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients after HCT

Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma

Results of Inter-B-NHL Ritux 2010 - Phase II Study of DA-EPOCH-R for Children and Adolescents with Primary Mediastinal Large B-Cell Lymphoma (PMLBL) on Behalf of European Intergroup for Childhood Non Hodgkin's Lymphoma (EICNHL) and Children's Oncology Group (COG)

Rapidly-Generated EBV-Specific T Cells (EBVST-cells) to Treat Type 2 Latency Lymphoma

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Infusion of Ex Vivo Expanded Allogeneic Cord Blood-Derived Natural Killer Cells in Combination with Autologous Stem Cell Transplantation for Multiple Myeloma: Results of a Phase I Study

Chimeric T Cells for Therapy of CD30+ Hodgkin and Non-Hodgkin Lymphomas

Graft Versus Leukemia Response without Graft Versus Host Disease Elicited By Adoptively Transferred Multivirus-Specific T-Cells

Natural Killer Cells In Pediatric Acute Lymphoblastic Leukemia Patients At Diagnosis Demonstrate An Inhibitory Phenotype and Reduced Cytolytic Capacity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only